Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
BOLT

Updated 10/6/2026, 11:57 AM ET.

BOLT

Bolt Biotherapeutics, Inc.

Sale$43,807

Yonehiro Grant

Chief Operating Officer

13,176 shat $3.32Filed Sep 21, 6:05 PM ETFiling
BOLT

Bolt Biotherapeutics, Inc.

Sale$26,072

Nemec Sarah

Senior VP, Finance and PAO

7,842 shat $3.32Filed Sep 21, 6:04 PM ETFiling
BOLT

Bolt Biotherapeutics, Inc.

Buy$1,973

Nemec Sarah

Senior VP, Finance and PAO

509 shat $3.88Filed Sep 21, 6:04 PM ETFiling
BOLT

Bolt Biotherapeutics, Inc.

Sale$58,402

Quinn William P.

President, CEO and CFO, Director

17,566 shat $3.32Filed Sep 21, 6:03 PM ETFiling
BOLT

Bolt Biotherapeutics, Inc.

Buy$2,469

Quinn William P.

President, CEO and CFO, Director

637 shat $3.88Filed Sep 21, 6:03 PM ETFiling

Read from public SEC filings. Not financial advice.